Geneos Wealth Management Inc. Acadia Pharmaceuticals Inc Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Sep 07, 2021	SELL	$22.22 - $44.01 $9,265 - $18,352	-417 Reduced 48.1%	450 $16,000
Q3 2018 Sep 07, 2021	SELL	$13.03 - $21.81 $29,969 - $50,163	-2,300 Reduced 72.62%	867 $17,000
Q1 2018 Sep 07, 2021	BUY	$22.47 - $32.33 $67,791 - $97,539	3,017 Added 2011.33%	3,167 $71,000
Q4 2017 Sep 07, 2021	BUY	$26.84 - $39.14 $4,026 - $5,871	150 New	150 $4,000
Q2 2017 Sep 07, 2021	SELL	N/A	-63 Closed	0 $0

Q3 2016 Sep 07, 2021	BUY	N/A	63 New	63 $2,000
Q2 2016 Sep 07, 2021	SELL	N/A	-1,000 Closed	0 $0
Q1 2016 Sep 07, 2021	BUY	N/A	1,000	1,000 $28,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.